Results 71 to 80 of about 374 (134)

Clinical pharmacology of vigabatrin. [PDF]

open access: yesBr J Clin Pharmacol, 1989
Schechter PJ.
europepmc   +1 more source

Acute renal failure and myopathy after treatment with aminocaproic acid. [PDF]

open access: yesBr Med J, 1980
Biswas CK   +4 more
europepmc   +1 more source

Real world evidence of treatment patterns in hereditary hemorrhagic telangiectasia

Blood
Hereditary hemorrhagic telangiectasia (HHT), is an inherited bleeding disorder characterized by recurrent epistaxis, mucocutaneous telangiectasia, gastrointestinal (GI) hemorrhage and arteriovenous malformations (AVMs).
Kristy Pahl   +4 more
semanticscholar   +1 more source

Spectrophotometric Assays for l-Lysine α-Oxidase and γ-Glutamylamine Cyclotransferase

, 2002
A new assay for l -lysine α-oxidase is described. In this assay, the oxidized product generated from l -lysine is reacted with semicarbazide to form α-keto-ϵ-aminocaproate semicarbazone.
J. Danson   +2 more
semanticscholar   +1 more source

Epsilon-Aminocaproic Acid (EACA)

Seminars in Thrombosis and Hemostasis, 2008
Epsilon-aminocaproic acid (EACA) is a synthetic inhibitor of the plasmin-plasminogen system. It is the only potent antifibrinolytic agent which is commercially available in the United States. Effective blood levels of the drug are readily obtainable with either oral or intravenous administration, with very high levels of the drug being found in the ...
J D, Griffin, L, Ellman
openaire   +2 more sources

Home - About - Disclaimer - Privacy